Encryption of EPCR by sPLA2-V induces cellular APC resistance. Functional EPCR loaded with a phosphatidylcholine (PCh) in its hydrophobic groove (green) promotes the generation of APC by the thrombin-thrombomodulin complex and supports APC's direct cytoprotective effects on cells. Secreted phospholipase A2 group V (sPLA2-V) changes the PCh in EPCR for a lysoPCh. This lysoPCh-loaded EPCR (red), or encrypted EPCR, is dysfunctional with regard to protein C and APC binding. Thus, sPLA2-V modified EPCR fails to promote APC generation by the thrombin-thrombomodulin complex and abrogates APC's direct cytoprotective effects on cells thereby inducing cellular APC resistance with potential implications for the susceptibility to thrombosis and inflammation.

Encryption of EPCR by sPLA2-V induces cellular APC resistance. Functional EPCR loaded with a phosphatidylcholine (PCh) in its hydrophobic groove (green) promotes the generation of APC by the thrombin-thrombomodulin complex and supports APC's direct cytoprotective effects on cells. Secreted phospholipase A2 group V (sPLA2-V) changes the PCh in EPCR for a lysoPCh. This lysoPCh-loaded EPCR (red), or encrypted EPCR, is dysfunctional with regard to protein C and APC binding. Thus, sPLA2-V modified EPCR fails to promote APC generation by the thrombin-thrombomodulin complex and abrogates APC's direct cytoprotective effects on cells thereby inducing cellular APC resistance with potential implications for the susceptibility to thrombosis and inflammation.

Close Modal

or Create an Account

Close Modal
Close Modal